Clinical characteristics of patients with affected inflammatory immunemediated diseases
Index de Enfermeria
; 31(2), 2022.
Article
in Spanish
| EMBASE | ID: covidwho-1965415
ABSTRACT
by Covid-19Objective:
Describe the incidence of Covid-19 by sex and specialty in patients with Immune-Mediated Inflammatory Disease (IMID).Methods:
Prospective observational study of patients in treatment at a Centre for ImmuneMediated Inflammatory Diseases, march to june 2020.Results:
The patients in follow-up were 1672, 3480 consultations were carried out, 2382 were telematic (68.4 %). The cases of covid-19 were 77 (4.60 %), were women 40 (51.98 %). The prevalent symptoms were seca (81.8 %), myalgia/arthralgia (77.9 %), headache (68.8 %), fever (55.8 %) and pneumonia (22.4 %). Statistical differences were found in symptoms by specialty myalgia / arthralgia (p=0.001), headache (p=0.011), fever (p=0.012). Hospital admission was required in 17 (22.10 %) patients and 3 (17.65 %) in the Intensive Care Unit.Conclusions:
Biological drug therapy was not associated with worse Covid-19 outcomes. Telematic consultations carried out by Advanced Nurse Practitioner ensured optimal follow-up, early detection and continuity of treatment.
adult; arthralgia; clinical feature; consultation; controlled study; coronavirus disease 2019; dermatology; early diagnosis; female; fever; follow up; headache; hospital admission; human; inflammatory bowel disease; intensive care unit; male; myalgia; note; nurse practitioner; nursing care; observational study; pneumonia; prospective study; rheumatology; telemedicine
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Prognostic study
Language:
Spanish
Journal:
Index de Enfermeria
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS